Literature DB >> 10812325

Showing neuropathy is related to increased mortality in diabetic patients - a survival analysis using an accelerated failure time model.

D V Coppini1, P A Bowtell, C Weng, P J Young, P H Sönksen.   

Abstract

Diabetic subjects still have a reduced life expectancy despite many potential advances in patient care. Furthermore, population-based studies in well-defined cohorts of patients, to investigate the reduced life expectancies, are generally lacking. Computerized baseline data on a cohort of diabetic patients first attending our clinic during 1982-1985 were used to identify risk factors for increased mortality. This was carried out using an accelerated failure time (ACF) model. Out of 794 patients entered into the model, 201 (25.3%) patients died between 1982 and 1995. Baseline microvascular diabetic complications (peripheral sensory neuropathy and nephropathy) were found to be associated with increased mortality in patients, indicating that these are important, often overlooked, markers for those at greatest risk. Patients with type I (insulin dependent) diabetes mellitus were also identified as being at greater risk.

Entities:  

Mesh:

Year:  2000        PMID: 10812325     DOI: 10.1016/s0895-4356(99)00170-5

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  37 in total

Review 1.  Risk factors for diabetic neuropathy and foot ulceration.

Authors:  A Adler
Journal:  Curr Diab Rep       Date:  2001-12       Impact factor: 4.810

2.  Management of painful diabetic neuropathy: what is new or in the pipeline for 2007?

Authors:  Dan Ziegler
Journal:  Curr Diab Rep       Date:  2007-12       Impact factor: 4.810

3.  Increased aortic stiffness predicts future development and progression of peripheral neuropathy in patients with type 2 diabetes: the Rio de Janeiro Type 2 Diabetes Cohort Study.

Authors:  Claudia R L Cardoso; Camila B M Moran; Fernanda S Marinho; Marcel T Ferreira; Gil F Salles
Journal:  Diabetologia       Date:  2015-06-05       Impact factor: 10.122

4.  Mortality associated with acute Charcot foot and neuropathic foot ulceration.

Authors:  Juliette van Baal; Richard Hubbard; Fran Game; William Jeffcoate
Journal:  Diabetes Care       Date:  2010-02-25       Impact factor: 19.112

5.  Functional disability and nursing resource use are predictive of antimicrobial resistance in nursing homes.

Authors:  Lillian Min; Andrzej Galecki; Lona Mody
Journal:  J Am Geriatr Soc       Date:  2015-04-08       Impact factor: 5.562

6.  Peripheral Neuropathy and All-Cause and Cardiovascular Mortality in U.S. Adults : A Prospective Cohort Study.

Authors:  Caitlin W Hicks; Dan Wang; Kunihiro Matsushita; B Gwen Windham; Elizabeth Selvin
Journal:  Ann Intern Med       Date:  2020-12-08       Impact factor: 25.391

7.  Effects of cardiac autonomic dysfunction on mortality risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.

Authors:  Rodica Pop-Busui; Gregory W Evans; Hertzel C Gerstein; Vivian Fonseca; Jerome L Fleg; Byron J Hoogwerf; Saul Genuth; Richard H Grimm; Marshall A Corson; Ronald Prineas
Journal:  Diabetes Care       Date:  2010-03-09       Impact factor: 19.112

8.  Autonomic and sensory nerve dysfunction in primary biliary cirrhosis.

Authors:  Katalin Keresztes; Ildikó Istenes; Aniko Folhoffer; Peter L Lakatos; Andrea Horvath; Timea Csak; Peter Varga; Peter Kempler; Ferenc Szalay
Journal:  World J Gastroenterol       Date:  2004-10-15       Impact factor: 5.742

Review 9.  Medial arterial calcification in diabetes and its relationship to neuropathy.

Authors:  W J Jeffcoate; L M Rasmussen; L C Hofbauer; F L Game
Journal:  Diabetologia       Date:  2009-09-12       Impact factor: 10.122

10.  Effect of intensive compared with standard glycemia treatment strategies on mortality by baseline subgroup characteristics: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.

Authors:  Jorge Calles-Escandón; Laura C Lovato; Denise G Simons-Morton; David M Kendall; Rodica Pop-Busui; Robert M Cohen; Denise E Bonds; Vivian A Fonseca; Faramarz Ismail-Beigi; Mary Ann Banerji; Alan Failor; Bruce Hamilton
Journal:  Diabetes Care       Date:  2010-01-26       Impact factor: 17.152

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.